Experimental therapy

Swiss doctors enquired with an international pharmaceutical company about the availability of a medicinal product not approved in Switzerland for the treatment of a fatal disease. This was intended for the treatment of a small number of patients for whom the available standard therapy was not suitable or all treatment options had been exhausted. We advised the company to enable availability in these cases.